|
1
|
Cho KR and Shih IeM: Ovarian cancer. Annu
Rev Pathol. 4:287–313. 2009. View Article : Google Scholar :
|
|
2
|
Swisher EM, Taniguchi T and Karlan BY:
Molecular scores to predict ovarian cancer outcomes: a worthy goal,
but not ready for prime time. J Natl Cancer Inst. 104:642–645.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gillis CN: Panax ginseng pharmacology: a
nitric oxide link? Biochem Pharmacol. 54:1–8. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liao B, Newmark H and Zhou R:
Neuroprotective effects of ginseng total saponin and ginsenosides
Rb1 and Rg1 on spinal cord neurons in vitro. Exp Neurol.
173:224–234. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nag SA, Qin JJ, Wang W, Wang MH, Wang H
and Zhang R: Ginsenosides as anticancer agents: in vitro and in
vivo activities, structure-activity relationships, and molecular
mechanisms of action. Front Pharmacol. 3:252012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lü JM, Yao Q and Chen C: Ginseng
compounds: an update on their molecular mechanisms and medical
applications. Curr Vasc Pharmacol. 7:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee SY, Kim GT, Roh SH, et al: Proteomic
analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human
colon cancer cell lines. Biosci Biotechnol Biochem. 73:811–816.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mochizuki M, Yoo YC, Matsuzawa K, et al:
Inhibitory effect of tumor metastasis in mice by saponins,
ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng.
Biol Pharm Bull. 18:1197–1202. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bae EA, Kim EJ, Park JS, Kim HS, Ryu JH
and Kim DH: Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1
and protein kinase A pathway in
lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial
cells. Planta Med. 72:627–633. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Keum YS, Han SS, Chun KS, et al:
Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced
cyclooxygenase-2 expression, NF-kappaB activation and tumor
promotion. Mutat Res. 523–524:75–85. 2003. View Article : Google Scholar
|
|
12
|
Cui W, Cheng L, Hu C, Li H, Zhang Y and
Chang J: Electrospun poly(L-lactide) fiber with ginsenoside rg3 for
inhibiting scar hyperplasia of skin. PLoS One. 8:e687712013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yue PY, Wong DY, Wu PK, et al: The
angiosuppressive effects of 20(R)-ginsenoside Rg3. Biochem
Pharmacol. 72:437–445. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JW and Dang CV: Cancer’s molecular
sweet tooth and the Warburg effect. Cancer Res. 66:8927–8930. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: the metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Diaz N, Minton S, Cox C, et al: Activation
of stat3 in primary tumors from high-risk breast cancer patients is
associated with elevated levels of activated SRC and survivin
expression. Clin Cancer Res. 12:20–28. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Germain D and Frank DA: Targeting the
cytoplasmic and nuclear functions of signal transducers and
activators of transcription 3 for cancer therapy. Clin Cancer Res.
13:5665–5669. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang SW and Sun YM: The IL-6/JA K/STAT3
pathway: Potential therapeutic strategies in treating colorectal
cancer (Review). Int J Oncol. 44:1032–1040. 2014.PubMed/NCBI
|
|
20
|
Zhu Q, Hu J, Meng H, Shen Y, Zhou J and
Zhu Z: S-phase cell cycle arrest, apoptosis, and molecular
mechanisms of aplasia ras homolog member I-induced human ovarian
cancer SKOV3 cell lines. Int J Gynecol Cancer. 24:629–634. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang S, Zhang LF, Zhang HW, et al: A
novel miR-155/miR-143 cascade controls glycolysis by regulating
hexokinase 2 in breast cancer cells. EMBO J. 31:1985–1998. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Demaria M, Giorgi C, Lebiedzinska M, et
al: A STAT3-mediated metabolic switch is involved in tumour
transformation and STAT3 addiction. Aging (Albany NY). 2:823–842.
2010.
|
|
23
|
Sawayama H, Ishimoto T, Sugihara H, et al:
Clinical impact of the Warburg effect in gastrointestinal cancer
(Review). Int J Oncol. 45:1345–1354. 2014.PubMed/NCBI
|
|
24
|
Kiuchi N, Nakajima K, Ichiba M, et al:
STAT3 is required for the gp130-mediated full activation of the
c-myc gene. J Exp Med. 189:63–73. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ando M, Uehara I, Kogure K, et al:
Interleukin 6 enhances glycolysis through expression of the
glycolytic enzymes hexokinase 2 and
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3. J Nippon
Med Sch. 77:97–105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim SM, Lee SY, Cho JS, et al: Combination
of ginsenoside Rg3 with docetaxel enhances the susceptibility of
prostate cancer cells via inhibition of NF-kappaB. Eur J Pharmacol.
631:1–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JY, Jung KH, Morgan MJ, et al:
Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3
via CHOP-mediated DR5 upregulation in human hepatocellular
carcinoma cells. Mol Cancer Ther. 12:274–285. 2013. View Article : Google Scholar
|
|
28
|
Liu CY, Tseng LM, Su JC, et al: Novel
sorafenib analogues induce apoptosis through SHP-1 dependent STAT3
inactivation in human breast cancer cells. Breast Cancer Res.
15:R632013. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mathupala SP, Ko YH and Pedersen PL:
Hexokinase-2 bound to mitochondria: cancer’s stygian link to the
‘Warburg Effect’ and a pivotal target for effective therapy. Semin
Cancer Biol. 19:17–24. 2009. View Article : Google Scholar :
|
|
30
|
Vander Heiden MG, Lunt SY, Dayton TL, et
al: Metabolic pathway alterations that support cell proliferation.
Cold Spring Harb Symp Quant Biol. 76:325–334. 2011. View Article : Google Scholar
|
